Pfizer has named Dr. Martin Mackay as president of Pfizer Global Research and Development; launched a stand-alone biotherapeutics and bioinnovation center under the direction of Dr. Corey Goodman; and named Dr. Briggs Morrison, who held senior research and development positions at Merck, as its new head of clinical development for the global research and development pipeline.
Source
No comments:
Post a Comment